Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Nuvalent, Inc. (NUVL)  
$0.00 0.00 (0.00%) as of 4:30 Tue 11/30


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 65,769,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Nuvalent is a biopharmaceutical company. Co.'s product candidate, NVL-520, is a ROS proto-oncogene 1 (ROS1)-selective inhibitor designed with the aim to address the clinical challenges of emergent treatment resistance, central nervous system (CNS)-related adverse events, and brain metastases that may limit the use of available ROS1 tyrosine kinase inhibitors. Co.'s another product candidate, NVL-655, is a brain-penetrant anaplastic lymphoma kinase (ALK)-selective inhibitor, designed with the aim to address the clinical challenges of emergent treatment resistance, CNS-related adverse events, and brain metastases that may limit the use of first-, second-, and third-generation ALK inhibitors.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 799,253
Total Buy Value $0 $0 $0 $26,774,976
Total People Bought 0 0 0 2
Total Buy Transactions 0 0 0 2
Total Shares Sold 1,212,833 1,454,179 1,660,039 1,942,739
Total Sell Value $87,684,648 $105,784,257 $115,993,702 $123,872,796
Total People Sold 5 7 8 8
Total Sell Transactions 16 25 47 82
End Date 2024-02-11 2023-11-10 2023-05-12 2022-05-12

   
Records found: 155
  Page 2 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Noci Darlene Chief Development Officer   •       –      –    2024-01-05 4 A $0.00 $0 D/D 33,300 33,300     -
   Miller Deborah Ann Chief Legal Officer   •       –      –    2024-01-05 4 A $0.00 $0 D/D 33,300 33,300     -
   Shair Matthew Director   –       •      –    2023-12-28 4 AS $75.20 $3,663,492 D/D (48,548) 1,724,698     -
   Shair Matthew Director   –       •      –    2023-12-27 4 AS $75.17 $75,170 D/D (1,000) 1,773,246     -
   Shair Matthew Director   –       •      –    2023-12-26 4 AS $74.22 $5,228,346 D/D (69,602) 1,774,246     -
   Miller Deborah Ann Chief Legal Officer   •       –      –    2023-12-19 4 S $75.00 $375,000 D/D (5,000) 0     -
   Miller Deborah Ann Chief Legal Officer   •       –      –    2023-12-19 4 OE $18.93 $94,650 D/D 5,000 5,000     -
   Miller Deborah Ann Chief Legal Officer   •       –      –    2023-12-18 4 S $75.82 $2,505,548 D/D (33,046) 0     -
   Miller Deborah Ann Chief Legal Officer   •       –      –    2023-12-18 4 OE $27.85 $920,331 D/D 33,046 33,046     -
   Protopapas Anna Director   –       •      –    2023-12-18 4 S $75.67 $378,350 D/D (5,000) 0     -
   Protopapas Anna Director   –       •      –    2023-12-18 4 OE $9.36 $46,800 D/D 5,000 5,000     -
   Noci Darlene Chief Development Officer   •       –      –    2023-12-18 4 S $75.82 $3,032,800 D/D (40,000) 0     -
   Noci Darlene Chief Development Officer   •       –      –    2023-12-18 4 OE $1.08 $188,139 D/D 40,000 40,000     -
   Balcom Alexandra Chief Financial Officer   •       –      –    2023-12-18 4 S $75.82 $2,274,600 D/D (30,000) 0     -
   Balcom Alexandra Chief Financial Officer   •       –      –    2023-12-18 4 OE $1.08 $32,400 D/D 30,000 30,000     -
   Shair Matthew Director   –       •      –    2023-11-28 4 AS $61.68 $566,303 D/D (9,150) 1,843,848     -
   Shair Matthew Director   –       •      –    2023-10-24 4 AS $50.63 $4,648,872 D/D (91,700) 1,852,998     -
   Noci Darlene Chief Development Officer   •       –      –    2023-10-04 4 AS $55.41 $1,119,702 D/D (20,000) 0     -
   Noci Darlene Chief Development Officer   •       –      –    2023-10-04 4 OE $1.08 $111,150 D/D 20,000 20,000     -
   Turner Christopher Durant Chief Medical Officer   •       –      –    2023-10-04 4 AS $51.32 $432,031 D/D (7,995) 14,513     -
   Turner Christopher Durant Chief Medical Officer   •       –      –    2023-10-04 4 OE $6.89 $55,086 D/D 7,995 22,508     -
   Noci Darlene Chief Development Officer   •       –      –    2023-10-02 4 AS $45.35 $137,649 D/D (3,000) 0     -
   Noci Darlene Chief Development Officer   •       –      –    2023-10-02 4 OE $1.08 $3,240 D/D 3,000 3,000     -
   Miller Deborah Ann Chief Legal Officer   •       –      –    2023-09-15 4 AS $47.43 $95,283 D/D (2,000) 0     -
   Miller Deborah Ann Chief Legal Officer   •       –      –    2023-09-15 4 OE $6.89 $13,780 D/D 2,000 2,000     -
  155 Records found
  1  2  3  4  5  6  7   
  Page 2 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us